Showing results (151-160 of 167) with videos related to

Sort By:
Pageof 17
Movement Disorders : Official Journal of the Movement Disorder Society|June 2, 2021
α-Synuclein Deposition in Sympathetic Nerve Fibers in Genetic Forms of Parkinson's DiseaseRisa Isonaka, David S Goldstein, William Zhu, et al.
Cell Reports|October 3, 2019
PINK1/Parkin Influences Cell Cycle by Sequestering TBK1 at Damaged Mitochondria, Inhibiting MitosisShireen A Sarraf, Dionisia P Sideris, Nikolaos Giagtzoglou, et al.
The Journal of Clinical Investigation|August 26, 2011
Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cellsKye-Young Kim, Mark V Stevens, M Hasina Akter, et al.
Aging and Disease|December 16, 2025
Phosphorylated Ubiquitin as a Clinical Biomarker for Mitochondrial Damage in Neurodegenerative DiseasesFabienne C Fiesel, Jens O Watzlawik, Michael G Heckman, et al.
Brain : a Journal of Neurology|May 31, 2022
Heterozygous PRKN mutations are common but do not increase the risk of Parkinson's diseaseWilliam Zhu, Xiaoping Huang, Esther Yoon, et al.
The Journal of Clinical Investigation|June 14, 2022
OMA1 mediates local and global stress responses against protein misfolding in CHCHD10 mitochondrial myopathyMario K Shammas, Xiaoping Huang, Beverly P Wu, et al.
The EMBO Journal|July 29, 2006
Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neuronsMark J Barsoum, Hua Yuan, Akos A Gerencser, et al.
Cells|September 27, 2024
Structural and Functional Characterization of the Most Frequent Pathogenic PRKN Substitution p.R275WBernardo A Bustillos, Liam T Cocker, Mathew A Coban, et al.
Brain : a Journal of Neurology|October 8, 2020
Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonismMax Borsche, Inke R König, Sylvie Delcambre, et al.
Molecular Cell|August 23, 2011
Hsp90-Cdc37 chaperone complex regulates Ulk1- and Atg13-mediated mitophagyJoung Hyuck Joo, Frank C Dorsey, Aashish Joshi, et al.
Pageof 17